Hyperwell editorial · 2 minute read
Explain the practical problem precisely
Tell the prescribing team whether the issue is pharmacy supply, cost, insurance, travel, or another barrier. Give dates when known and keep the current label available. This helps distinguish an administrative delay from a treatment decision. Ask which person handles each part of the problem so messages do not circulate without an owner.
Ask which decisions need clinical review
Clarify what the clinician needs to know before giving instructions about a delay or change. A pharmacy stock issue does not establish that a different product is appropriate. Avoid dose conversions, restarting advice, or replacement purchases based on forums. Keep proposed changes within the prescribing relationship.
Clarify financial and follow-up terms
If a program fee continues during an interruption, ask what services remain available and whether written terms address a pause. Ask when follow-up is needed and how to document instructions. Hyperwell has not published interruption, refund, or coverage policies. Confirm the actual practice terms rather than assuming they match another program.
Make the conversation yours
Questions to take with you.
- Who is coordinating this access issue?
- Which changes require a prescribing decision?
- What happens to appointments and program fees during a delay?
